findmyKOL
Clinical trialNCT01705145CompletedPhase 3Interventional

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation

SponsorVertex Pharmaceuticals IncorporatedEnrollment35Cystic Fibrosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Facility name not stated

    Vancouver, Canada

United Kingdom
  • Facility name not stated

    Edinburgh, United Kingdom

  • Facility name not stated

    Liverpool, United Kingdom

  • Facility name not stated

    London, United Kingdom

United States
  • Facility name not stated

    Birmingham, Alabama, United States

  • Facility name not stated

    Aurora, Colorado, United States

  • Facility name not stated

    Atlanta, Georgia, United States

  • Facility name not stated

    Indianapolis, Indiana, United States

  • Facility name not stated

    Lexington, Kentucky, United States

  • Facility name not stated

    Boston, Massachusetts, United States

  • Facility name not stated

    Detroit, Michigan, United States

  • Facility name not stated

    Grand Rapids, Michigan, United States

  • Facility name not stated

    Minneapolis, Minnesota, United States

  • Facility name not stated

    Kansas City, Missouri, United States

  • Facility name not stated

    Omaha, Nebraska, United States

  • Facility name not stated

    Pittsburgh, Pennsylvania, United States

  • Facility name not stated

    Salt Lake City, Utah, United States

  • Facility name not stated

    Charlottesville, Virginia, United States

  • Facility name not stated

    Richmond, Virginia, United States

  • Facility name not stated

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2013
Primary completion
31 Mar 2014
Completion
31 Mar 2014
Last update posted
5 Apr 2016
Registered enrollment
35
Registry id
NCT01705145

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.